Otrivin Baby and Paed Nasal Product Range
Otrivin offers a range of specially formulated products tailored to patients’ needs. Find out how they can support the work you do, and how they can benefit your patients.
OTRIVIN PAED Nasal Drops
S1 OTRIVIN PAED Drops. Each 1 ml contains 0,5 mg of xylometazoline hydrochloride. Preservative: benzalkonium chloride 0.01 % m/v. Reg. no.: H/16.1/1381.
S1 OTRIVIN PAED Nasal Metered-dose Spray. Each 1 ml contains 0, 5 mg of xylometazoline hydrochloride. Preservative: Benzalkonium chloride 0.01 % m/v. Reg. no.: H/16.1/1381.
Applicant: GlaxoSmithKline Consumer Healthcare South Africa (Pty) Limited, 39 Hawkins Avenue, Epping Industria 1, Cape Town, 7460
Company reg. no.: 2014/173930/07. For full prescribing information refer to the professional information approved by the medicines regulatory authority. Always read label prior to use.
For any further information, including safety and adverse reactions, please contact the GSK Hotline on 0800 007 018 or mystory.za@haleon.com.
Trademarks are owned by or licensed to the Haleon group of companies.
Otrivin Baby Care - Moisturizing Nasal Spray
Haleon South Africa (Pty) Ltd. 17 Muswell Road South, Block D, Wedgefield, Phase 2, Bryanston, 2191. Reg. No: 2014/173930/07.
For any further information, including safety information, please contact Haleon on 0800 007 018 or mystory.za@haleon.com
Trademarks are owned by or licensed to Haleon group of companies.
Always read the carton and leaflet for full use instructions before use.
PM-ZA-OTRI-21-00049Date of Preparation: October 2023